Literature DB >> 18024988

European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.

N Perry1, M Broeders, C de Wolf, S Törnberg, R Holland, L von Karsa.   

Abstract

Breast cancer is a major cause of suffering and death and is of significant concern to many women. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. The potential harm caused by mammography includes the creation of unnecessary anxiety and morbidity, inappropriate economic cost and the use of ionising radiation. It is for this reason that the strongest possible emphasis on quality control and quality assurance is required. Development of the European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis has been an initiative within the Europe Against Cancer Programme. The fourth edition of the multidisciplinary guidelines was published in 2006 and comprises approximately 400 pages divided into 12 chapters prepared by >200 authors and contributors. The multidisciplinary editorial board has prepared a summary document to provide an overview of the fundamental points and principles that should support any quality screening or diagnostic service. This document includes a summary table of key performance indicators and is presented here in order to make these principles and standards known to a wider scientific community.

Entities:  

Mesh:

Year:  2007        PMID: 18024988     DOI: 10.1093/annonc/mdm481

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  172 in total

1.  Does digital mammography in a decentralized breast cancer screening program lead to screening performance parameters comparable with film-screen mammography?

Authors:  Chantal Van Ongeval; Andre Van Steen; Gretel Vande Putte; Federica Zanca; Hilde Bosmans; Guy Marchal; Erik Van Limbergen
Journal:  Eur Radiol       Date:  2010-05-09       Impact factor: 5.315

2.  A simple scoring system for breast MRI interpretation: does it compensate for reader experience?

Authors:  Maria Adele Marino; Paola Clauser; Ramona Woitek; Georg J Wengert; Panagiotis Kapetas; Maria Bernathova; Katja Pinker-Domenig; Thomas H Helbich; Klaus Preidler; Pascal A T Baltzer
Journal:  Eur Radiol       Date:  2015-10-29       Impact factor: 5.315

3.  Earlier diagnosis of breast cancer outside of a screening programme.

Authors:  Chris I Flowers
Journal:  Nat Rev Clin Oncol       Date:  2013-07-23       Impact factor: 66.675

4.  Evaluation of mean glandular dose and modulation transfer function for different tube potentials and target-filter combinations in computed radiography mammography.

Authors:  Siti Aishah Abdul Aziz; Abdul Khaliq Mohd Saparudin; Ahmad Zaky Harun
Journal:  Malays J Med Sci       Date:  2013-05

5.  A high omega-3 fatty acid diet mitigates murine pancreatic precancer development.

Authors:  Matthew J Strouch; Yongzeng Ding; Mohammad R Salabat; Laleh G Melstrom; Kevin Adrian; Christopher Quinn; Carolyn Pelham; Sambasiva Rao; Thomas E Adrian; David J Bentrem; Paul J Grippo
Journal:  J Surg Res       Date:  2009-05-15       Impact factor: 2.192

6.  Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey.

Authors:  Fernanda Dourado; Helena Carreira; Nuno Lunet
Journal:  Eur J Public Health       Date:  2012-08-08       Impact factor: 3.367

7.  Efficacy and cost-effectiveness of stereotactic vacuum-assisted core biopsy of nonpalpable breast lesions: analysis of 602 biopsies performed over 5 years.

Authors:  A Luparia; M Durando; P Campanino; E Regini; D Lucarelli; A Talenti; G Mattone; G Mariscotti; A Sapino; G Gandini
Journal:  Radiol Med       Date:  2011-01-12       Impact factor: 3.469

8.  Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.

Authors:  Hubert Bickel; Katja Pinker; Stephan Polanec; Heinrich Magometschnigg; Georg Wengert; Claudio Spick; Wolfgang Bogner; Zsuzsanna Bago-Horvath; Thomas H Helbich; Pascal Baltzer
Journal:  Eur Radiol       Date:  2016-08-30       Impact factor: 5.315

9.  Ki-67 and caspase expression in breast carcinoma: does variance in locational sampling exist?

Authors:  Filinte Deniz; Kaymakci Dilek; Mollamemisoglu Hande; Ugurlu M Umit; Kaya Handan
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.

Authors:  A Bordoni; N M Probst-Hensch; L Mazzucchelli; A Spitale
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.